Cas No.: | 1403859-14-2 |
Chemical Name: | 2-(Tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)pyrimidine-5-carboxamide |
Synonyms: | 2-(tert-butylamino)-4-[[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino]pyrimidine-5-carboxamide;2-(tert-butylamino)-4-{[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino}pyrimidine-5-carboxamide;2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide;2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)pyrimidine-5-carboxamide;CC-90001 |
SMILES: | O([H])[C@]1([H])C([H])([H])[C@@]([H])(C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])N([H])C1C(C(N([H])[H])=O)=C([H])N=C(N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])N=1 |
Formula: | C16H27N5O2 |
M.Wt: | 321.4179 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | CC-90001 is a potent, selective and orally active inhibitor of c-Jun N-terminal kinase (JNK). CC-90001 shows 12.9-fold selectivity for JNK1 over JNK2 in a cell-based model. CC-90001 can be used for the research of idiopathic pulmonary fibrosis. |